News Sanofi's Dengue vaccine launch turns into nightmare Philippines halts vaccination programme on safety issues
News Brazil begins dengue immunisation with Sanofi’s Dengvaxia Burden of Dengue fever far greater than Zika
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.